Literature DB >> 8444222

Low iron stores in infants and children with treated phenylketonuria: a population at risk for iron-deficiency anaemia and associated cognitive deficits.

J L Bodley1, V J Austin, W B Hanley, J T Clarke, S Zlotkin.   

Abstract

A retrospective study of 53 patients with phenylketonuria (PKU), whose disease was managed with a low-phenylalanine diet, revealed a high incidence of iron depletion (as reflected by subnormal serum ferritin concentrations). Serum ferritin concentrations under 10 micrograms/l were found in one out of six infants aged 5-12 months. Concentrations under 16 micrograms/l were found in 16 of 22 children aged 1-3 years and in 11 of 25 children aged 4-12 years. Dietary iron, estimated from prescribed intakes of medical foods, exceeded the Canadian recommended nutrient intake, suggesting that low stores of iron may be secondary to reduced bioavailability and absorption of iron. These findings suggest that the current dietary management of PKU is associated with an increased risk for low iron stores. Investigators have reported an association in young children between iron-deficiency anaemia and both cognitive and motor disturbances. Children with PKU, already at risk of neurological damage because of phenylalanine neurotoxicity, may be at increased risk as a result of iron depletion. Serum ferritin as well as haemoglobin concentration should be monitored, along with plasma phenylalanine and tyrosine, to ensure optimum treatment of affected children.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8444222     DOI: 10.1007/bf02072491

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  21 in total

1.  Effect of ascorbic acid on iron absorption.

Authors:  H BRISE; L HALLBERG
Journal:  Acta Med Scand Suppl       Date:  1962

2.  Intellectual and school performances in early-treated classical PKU patients. The French collaborative study.

Authors:  J M Saudubray; F Rey; H Ogier; V Abadie; J P Farriaux; J Ghisolfi; P Guibaud; J Rey; M Vidailhet
Journal:  Eur J Pediatr       Date:  1987       Impact factor: 3.183

3.  The effects of diet discontinuation in children with phenylketonuria.

Authors:  R Koch; C G Azen; N Hurst; E G Friedman; K Fishler
Journal:  Eur J Pediatr       Date:  1987       Impact factor: 3.183

4.  Inadequate iron availability as a possible cause of low serum carnitine concentrations in patients with phenylketonuria.

Authors:  H Böhles; K Ullrich; W Endres; A W Behbehani; U Wendel
Journal:  Eur J Pediatr       Date:  1991-04       Impact factor: 3.183

5.  Intelligence and quality of dietary treatment in phenylketonuria.

Authors:  I Smith; M G Beasley; A E Ades
Journal:  Arch Dis Child       Date:  1990-05       Impact factor: 3.791

Review 6.  Iron deficiency and the immune response.

Authors:  P R Dallman
Journal:  Am J Clin Nutr       Date:  1987-08       Impact factor: 7.045

7.  Blood phenylalanine levels and intelligence of 10-year-old children with PKU in the National Collaborative Study.

Authors:  K Michals; C Azen; P Acosta; R Koch; R Matalon
Journal:  J Am Diet Assoc       Date:  1988-10

8.  Effect of age at loss of dietary control on intellectual performance and behavior of children with phenylketonuria.

Authors:  N A Holtzman; R A Kronmal; W van Doorninck; C Azen; R Koch
Journal:  N Engl J Med       Date:  1986-03-06       Impact factor: 91.245

9.  Admissions of phenylketonuric patients to residential institutions before and after screening programs of the newborn infant.

Authors:  R A MacCready
Journal:  J Pediatr       Date:  1974-09       Impact factor: 4.406

10.  Iron deficiency anemia and iron therapy effects on infant developmental test performance.

Authors:  B Lozoff; G M Brittenham; A W Wolf; D K McClish; P M Kuhnert; E Jimenez; R Jimenez; L A Mora; I Gomez; D Krauskoph
Journal:  Pediatrics       Date:  1987-06       Impact factor: 7.124

View more
  6 in total

Review 1.  Stem cell therapy for inherited metabolic disorders of the liver.

Authors:  Susan Ellor; Thomas Shupe; Bryon Petersen
Journal:  Exp Hematol       Date:  2008-04-02       Impact factor: 3.084

2.  Normal serum levels of vitamin B12 and folic acid in children with phenylketonuria.

Authors:  P Strisciuglio; D Concolino; M T Moricca; L Rivalta; G Parlato
Journal:  Eur J Pediatr       Date:  1995-10       Impact factor: 3.183

3.  Haematological findings in children with inborn errors of metabolism.

Authors:  Betul Tavil; Hatice Serapl Kalkanoglu Sivri; Turgay Coskun; Aytemiz Gurgey; Emel Ozyurek; Ali Dursun; Aysegul Tokatli; Cigdem Altay; Fatma Gumruk
Journal:  J Inherit Metab Dis       Date:  2006-08-12       Impact factor: 4.982

4.  Recommendations for protein and amino acid intake in phenylketonuric patients.

Authors:  F Cockburn; B J Clark
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

Review 5.  The complete European guidelines on phenylketonuria: diagnosis and treatment.

Authors:  A M J van Wegberg; A MacDonald; K Ahring; A Bélanger-Quintana; N Blau; A M Bosch; A Burlina; J Campistol; F Feillet; M Giżewska; S C Huijbregts; S Kearney; V Leuzzi; F Maillot; A C Muntau; M van Rijn; F Trefz; J H Walter; F J van Spronsen
Journal:  Orphanet J Rare Dis       Date:  2017-10-12       Impact factor: 4.123

6.  Intellectual and Developmental Status in Children With Hyperphenylalaninemia and PKU Who Were Screened in a National Program.

Authors:  Parisa Aghasi; Arya Setoodeh; Azadeh Sayarifard; Maryam Rashidiyan; Fatemeh Sayarifard; Ali Rabbani; Javad Mahmoudi-Gharaei
Journal:  Iran J Pediatr       Date:  2015-12-23       Impact factor: 0.364

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.